Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03BA02	AERONIDE	G	Budesonide - 400mcg	400mcg	Capsule, inhalation	2,116,552 L.L
L02BX03	ABLAX 250	G	Abiraterone acetate - 250mg	250mg	Tablet	L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,104,639 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.5%	Injectable solution	179,456 L.L
C09CA06	ANDESART 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	498,566 L.L
C10AA07	SINLIP	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	563,070 L.L
D10AF01	CLINIDERM	G	Clindamycin (phosphate) - 1%	1%	Gel	712,876 L.L
J01DD01	CEFOTAXIME PANPHARMA	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution	6,127,922 L.L
J01MA14	MOFLOXINE	G	Moxifloxacin (HCl) - 400mg/250ml	400mg/250ml	Injectable solution	1,638,144 L.L
L01AX03	TEGOZOL	G	Temozolomide - 100mg	100mg	Capsule	5,012,533 L.L
M01AH05	JOSWE COXIT 120	G	Etoricoxib - 120mg	120mg	Tablet, film coated	517,379 L.L
N02BE01	ADOL	G	Paracetamol - 250mg/5ml	250mg/5ml	Suspension, alcohol free	192,169 L.L
N05AH03	OLANZAMED	G	Olanzapine - 5mg	5mg	Tablet	665,522 L.L
S01BC04	FLUROPTIC	G	Flurbiprofen sodium - 0.03% w/v	0.03% w/v	Drops solution	223,078 L.L
L01EF01	PALBRANCE 125	G	Palbociclib - 125mg	125mg	Capsule	L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	581,884 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.5%	Injectable solution	163,184 L.L
C09CA06	ARKANDA 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	639,925 L.L
C10AA07	SUPERSTAT	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, coated	517,379 L.L
G04CA02	APO-TAMSULOSIN CR	G	Tamsulosin HCl - 0.4mg	0.4mg	Tablet	607,417 L.L
J01DD01	CLAFOCARE	G	Cefotaxime (sodium) - 1g	1g	Injectable powder for solution	8,031,731 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 100mg	100mg	Capsule, hard	5,590,385 L.L
N02BE01	PARACETAMOL PANPHARMA	G	Paracetamol - 10mg/ml	10mg/ml	Injectable solution	1,959,322 L.L
N05AH03	OLANZAPINE ARROW	G	Olanzapine - 5mg	5mg	Tablet	670,577 L.L
S01CA01	API-TOBRASON	G	Dexamethasone - 1mg/ml, Tobramycin - 3mg/ml		Drops suspension	294,302 L.L
A02BC02	PANTO TAD	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, gastroresistant	470,345 L.L
A11AA	CAL-VIT	G	Riboflavine - 9mg/100ml, Cyanocobalamine - 570mcg/100ml, Pyridoxine HCl - 35mg/100ml, Thiamine HCl - 190mg/100ml, Inositol - 150mg/100ml, Nicotinamide - 120mg/100ml, Calcium Pantothenate - 27mg/100ml, Sodium hypophosphite - 70mg/100ml		Syrup	163,821 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 10g/20ml	50%	Injectable solution	5,038,066 L.L
C09CA06	CANDESARTAN BIOGARAN	G	Candesartan cilexetil - 8mg	8mg	Tablet, scored	434,061 L.L
C10AA07	UBSATOR-CA	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	499,142 L.L